Latest News and Press Releases

Agreement demonstrates PanTera’s unique ability to support the radionuclide therapeutics industry in bringing new cancer treatments to patients Mol, Belgium, February 13, 2023: PanTera, the Belgian...

Acquisition complémentaire en vue de poursuivre la stratégie d'expansion d’IBA pour devenir le leader mondial du marché de l’assurance qualité en radiothérapie et en imagerie médicale. ...

Highly complementary acquisition continues IBA’s expansion strategy to lead the Radiotherapy, Medical Imaging Dosimetry and Quality Assurance markets globally Louvain-la-Neuve, Belgium, February 9,...

  (article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 5 février 2024, 18:00 Résumé de la notification IBA...

  (Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, February 5, 2024 18:00 Summary of the notification IBA (Ion Beam...

    (Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, January 31, 2024 01:00 Summary of the notification IBA (Ion Beam...

  (article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 31 janvier 2024, 01:00 Résumé de la notification ...

Cyclotron de 70 MeV désormais pleinement opérationnel suite à la finalisation des tests d’acceptation. Louvain-la-Neuve, Belgique, le 23 janvier 2024 - IBA (Ion Beam Applications S.A., EURONEXT),...

Successful completion of contractual site acceptance tests, with 70 MeV cyclotron now fully operational  Louvain-la-Neuve, Belgium, January 23, 2024 – IBA (Ion Beam Applications S.A., EURONEXT), the...

IBA – TRANSPARENCY NOTIFICATION (Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, January 9th, 2024, 18:00 Summary of the...